CYCLOPROPYLAMINE DERIVATIVES USEFUL AS LSD1 INHIBITORS
1 Assignment
0 Petitions
Accused Products
Abstract
The invention relates to methods and compositions for the treatment or prevention of protein conformation disorders. In particular, the invention relates to an LSD1 inhibitor for use in treating or preventing a protein conformation disorder, such as, e.g., Huntington Disease.
-
Citations
105 Claims
-
1-21. -21. (canceled)
- 22. A method of treating or preventing a cognitive symptom in an individual having a protein conformation disorder comprising identifying an individual in need of such treatment and administering to said individual for a sufficient period of time an amount of an LSD1 inhibitor sufficient to improve the cognitive symptom or reduce the rate of decline of the cognitive symptom thereby treating or preventing said cognitive symptom.
-
24-27. -27. (canceled)
- 29. A method of treating or preventing a motor symptom in an individual having a protein conformation disorder comprising identifying an individual in need of such treatment and administering to said individual for a sufficient period of time an amount of an LSD1 inhibitor sufficient to reduce the rate of decline in said motor symptom thereby treating or preventing said motor symptom.
-
31-35. -35. (canceled)
- 36. A method of increasing longevity in an individual having a protein conformation disorder comprising identifying an individual in need of such treatment and administering to said individual for a sufficient period of time an amount of an LSD1 inhibitor sufficient to increase longevity.
-
38-42. -42. (canceled)
-
48-73. -73. (canceled)
-
76-77. -77. (canceled)
-
79-84. -84. (canceled)
-
86. (canceled)
-
88-90. -90. (canceled)
-
92-98. -98. (canceled)
-
100-103. -103. (canceled)
-
105-115. -115. (canceled)
Specification